Serious side effects of amantadine: Rethinking the benefits and risks of medications for MS fatigue

Abstract

Keywords

Amantadine fatigue

Get full access to this article

View all access options for this article.

References

Young

Mills

Rog

, et al. Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy. J Neurol Sci 2021; 426: 117437.

Rocca

Valsasina

Colombo

, et al. Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadine. Eur J Neurol 2021; 28(7): 2249–2258.

Nourbakhsh

Revirajan

Morris

, et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: A randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol 2021; 20(1): 38–48.

Bradley

. Delayed amantadine toxicity causing apparent progression of multiple sclerosis. Mult Scler 2021. Epub ahead of print. DOI: 10.1177/13524585211035737.